Abstract
Combined transoral-transcervical approach has been used for the resection of the most or opharyngeal cancer without invasion to the mandible, medial pterygoid muscle or nasopharygeal space. This approach enables to get better results cosmetically and functionally than the mandibular swing approach. However, in recent years, cisplatin-based concurrent chemoradiotherapy (CCRT) has been widely employed in the treatment of even advanced oropharyngeal cancer with the intent of presenting swallow and speech. After CCRT, more than 70% of the patients with stage III, IV oropharyngeal cancer showed CR at our institute and the CR persisted for more than 18 months in 70% of these patients. Salvage surgery for the remnant tumor also had a good result, however the result was poor for the recurrent tumor after CCRT. We discussed the choice of the surgery approach and of treatment modality.
